Titelia

Holdings of SABBY MANAGEMENT, LLC

11 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 99.7 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 95.5 %
  • IL 4.5 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US102.8M $95.55 %
2IL1131.9K $4.45 %

Positions

RankCompanySharesValueWeight
1State Street SPDR S&P 500 ETF Trust 2,7341.8M $
2SENESTECH INC 218,533358.4K $
3MOLECULIN BIOTECH INC 75,021171.8K $
4ARCADIA BIOSCIENCES INC 114,554158.1K $
5Can-Fite BioPharma Ltd 42,559131.9K $
6REVELATION BIOSCIENCES INC 99,432119.3K $
7CALIDI BIOTHERAPEUTICS INC 434,903103.9K $
8BLUEJAY DIAGNOSTICS INC 28,72652.9K $
9LYRA THERAPEUTICS INC 104,05951.1K $
10TEMPEST THERAPEUTICS INC 17,85629.3K $
11BNB PLUS CORP 13,5418.7K $